USA Dengue Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Dengue Vaccine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Dengue Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Dengue Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Takeda Pharmaceuticals

    • GeneOne Life Sciences

    • US NIH

    • Medigen Biologics

    • Vabiotec

    • Merck Sharp & Dohme

    • GlaxoSmithKline

    • Sanofi

    • Panacea Biotec

    • Sun Pharmaceutical

    By Type:

    • CYD-TDV

    • DENVax or TAK-003

    • TetraVax-DV

    • TDENV PIV

    • V180

    • DNA vaccines

    By End-User:

    • Government institutions

    • Hospitals

    • NGOs

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dengue Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Dengue Vaccine Market Size and Growth Rate of CYD-TDV from 2016 to 2027

      • 1.3.2 USA Dengue Vaccine Market Size and Growth Rate of DENVax or TAK-003 from 2016 to 2027

      • 1.3.3 USA Dengue Vaccine Market Size and Growth Rate of TetraVax-DV from 2016 to 2027

      • 1.3.4 USA Dengue Vaccine Market Size and Growth Rate of TDENV PIV from 2016 to 2027

      • 1.3.5 USA Dengue Vaccine Market Size and Growth Rate of V180 from 2016 to 2027

      • 1.3.6 USA Dengue Vaccine Market Size and Growth Rate of DNA vaccines from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Dengue Vaccine Market Size and Growth Rate of Government institutions from 2016 to 2027

      • 1.4.2 USA Dengue Vaccine Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.3 USA Dengue Vaccine Market Size and Growth Rate of NGOs from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Dengue Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dengue Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of CYD-TDV

      • 3.4.2 Market Size and Growth Rate of DENVax or TAK-003

      • 3.4.3 Market Size and Growth Rate of TetraVax-DV

      • 3.4.4 Market Size and Growth Rate of TDENV PIV

      • 3.4.5 Market Size and Growth Rate of V180

      • 3.4.6 Market Size and Growth Rate of DNA vaccines

    4 Segmentation of Dengue Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dengue Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Dengue Vaccine in Government institutions

      • 4.4.2 Market Size and Growth Rate of Dengue Vaccine in Hospitals

      • 4.4.3 Market Size and Growth Rate of Dengue Vaccine in NGOs

    5 Market Analysis by Regions

    • 5.1 USA Dengue Vaccine Production Analysis by Regions

    • 5.2 USA Dengue Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Dengue Vaccine Landscape Analysis

    • 6.1 West USA Dengue Vaccine Landscape Analysis by Major Types

    • 6.2 West USA Dengue Vaccine Landscape Analysis by Major End-Users

    7 South USA Dengue Vaccine Landscape Analysis

    • 7.1 South USA Dengue Vaccine Landscape Analysis by Major Types

    • 7.2 South USA Dengue Vaccine Landscape Analysis by Major End-Users

    8 Middle West USA Dengue Vaccine Landscape Analysis

    • 8.1 Middle West USA Dengue Vaccine Landscape Analysis by Major Types

    • 8.2 Middle West USA Dengue Vaccine Landscape Analysis by Major End-Users

    9 Northeast USA Dengue Vaccine Landscape Analysis

    • 9.1 Northeast USA Dengue Vaccine Landscape Analysis by Major Types

    • 9.2 Northeast USA Dengue Vaccine Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Takeda Pharmaceuticals

        • 10.1.1 Takeda Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 GeneOne Life Sciences

        • 10.2.1 GeneOne Life Sciences Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 US NIH

        • 10.3.1 US NIH Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Medigen Biologics

        • 10.4.1 Medigen Biologics Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Vabiotec

        • 10.5.1 Vabiotec Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Merck Sharp & Dohme

        • 10.6.1 Merck Sharp & Dohme Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 GlaxoSmithKline

        • 10.7.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Sanofi

        • 10.8.1 Sanofi Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Panacea Biotec

        • 10.9.1 Panacea Biotec Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Sun Pharmaceutical

        • 10.10.1 Sun Pharmaceutical Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Dengue Vaccine Market Size and Growth Rate of CYD-TDV from 2016 to 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of DENVax or TAK-003 from 2016 to 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of TetraVax-DV from 2016 to 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of TDENV PIV from 2016 to 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of V180 from 2016 to 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of DNA vaccines from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of Government institutions from 2016 to 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Dengue Vaccine Market Size and Growth Rate of NGOs from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Dengue Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Dengue Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Dengue Vaccine

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dengue Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Dengue Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of CYD-TDV

    • Figure Market Size and Growth Rate of DENVax or TAK-003

    • Figure Market Size and Growth Rate of TetraVax-DV

    • Figure Market Size and Growth Rate of TDENV PIV

    • Figure Market Size and Growth Rate of V180

    • Figure Market Size and Growth Rate of DNA vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Dengue Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Dengue Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Government institutions

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of NGOs

    • Table USA Dengue Vaccine Production by Regions

    • Table USA Dengue Vaccine Production Share by Regions

    • Figure USA Dengue Vaccine Production Share by Regions in 2016

    • Figure USA Dengue Vaccine Production Share by Regions in 2021

    • Figure USA Dengue Vaccine Production Share by Regions in 2027

    • Table USA Dengue Vaccine Consumption by Regions

    • Table USA Dengue Vaccine Consumption Share by Regions

    • Figure USA Dengue Vaccine Consumption Share by Regions in 2016

    • Figure USA Dengue Vaccine Consumption Share by Regions in 2021

    • Figure USA Dengue Vaccine Consumption Share by Regions in 2027

    • Table West USA Dengue Vaccine Consumption by Types from 2016 to 2027

    • Table West USA Dengue Vaccine Consumption Share by Types from 2016 to 2027

    • Figure West USA Dengue Vaccine Consumption Share by Types in 2016

    • Figure West USA Dengue Vaccine Consumption Share by Types in 2021

    • Figure West USA Dengue Vaccine Consumption Share by Types in 2027

    • Table West USA Dengue Vaccine Consumption by End-Users from 2016 to 2027

    • Table West USA Dengue Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Dengue Vaccine Consumption Share by End-Users in 2016

    • Figure West USA Dengue Vaccine Consumption Share by End-Users in 2021

    • Figure West USA Dengue Vaccine Consumption Share by End-Users in 2027

    • Table South USA Dengue Vaccine Consumption by Types from 2016 to 2027

    • Table South USA Dengue Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South USA Dengue Vaccine Consumption Share by Types in 2016

    • Figure South USA Dengue Vaccine Consumption Share by Types in 2021

    • Figure South USA Dengue Vaccine Consumption Share by Types in 2027

    • Table South USA Dengue Vaccine Consumption by End-Users from 2016 to 2027

    • Table South USA Dengue Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Dengue Vaccine Consumption Share by End-Users in 2016

    • Figure South USA Dengue Vaccine Consumption Share by End-Users in 2021

    • Figure South USA Dengue Vaccine Consumption Share by End-Users in 2027

    • Table Middle West USA Dengue Vaccine Consumption by Types from 2016 to 2027

    • Table Middle West USA Dengue Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Dengue Vaccine Consumption Share by Types in 2016

    • Figure Middle West USA Dengue Vaccine Consumption Share by Types in 2021

    • Figure Middle West USA Dengue Vaccine Consumption Share by Types in 2027

    • Table Middle West USA Dengue Vaccine Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Dengue Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Dengue Vaccine Consumption Share by End-Users in 2016

    • Figure Middle West USA Dengue Vaccine Consumption Share by End-Users in 2021

    • Figure Middle West USA Dengue Vaccine Consumption Share by End-Users in 2027

    • Table Northeast USA Dengue Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast USA Dengue Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Dengue Vaccine Consumption Share by Types in 2016

    • Figure Northeast USA Dengue Vaccine Consumption Share by Types in 2021

    • Figure Northeast USA Dengue Vaccine Consumption Share by Types in 2027

    • Table Northeast USA Dengue Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Dengue Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Dengue Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast USA Dengue Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast USA Dengue Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

    • Table Company Profile and Development Status of GeneOne Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneOne Life Sciences

    • Figure Sales and Growth Rate Analysis of GeneOne Life Sciences

    • Figure Revenue and Market Share Analysis of GeneOne Life Sciences

    • Table Product and Service Introduction of GeneOne Life Sciences

    • Table Company Profile and Development Status of US NIH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of US NIH

    • Figure Sales and Growth Rate Analysis of US NIH

    • Figure Revenue and Market Share Analysis of US NIH

    • Table Product and Service Introduction of US NIH

    • Table Company Profile and Development Status of Medigen Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medigen Biologics

    • Figure Sales and Growth Rate Analysis of Medigen Biologics

    • Figure Revenue and Market Share Analysis of Medigen Biologics

    • Table Product and Service Introduction of Medigen Biologics

    • Table Company Profile and Development Status of Vabiotec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vabiotec

    • Figure Sales and Growth Rate Analysis of Vabiotec

    • Figure Revenue and Market Share Analysis of Vabiotec

    • Table Product and Service Introduction of Vabiotec

    • Table Company Profile and Development Status of Merck Sharp & Dohme

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Sharp & Dohme

    • Figure Sales and Growth Rate Analysis of Merck Sharp & Dohme

    • Figure Revenue and Market Share Analysis of Merck Sharp & Dohme

    • Table Product and Service Introduction of Merck Sharp & Dohme

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Panacea Biotec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec

    • Figure Sales and Growth Rate Analysis of Panacea Biotec

    • Figure Revenue and Market Share Analysis of Panacea Biotec

    • Table Product and Service Introduction of Panacea Biotec

    • Table Company Profile and Development Status of Sun Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical

    • Table Product and Service Introduction of Sun Pharmaceutical


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.